Motor cortex abnormalities in amyotrophic lateral sclerosis with transcranial direct-current stimulation
Angelo Quartarone1, Nicolas Lang, Vincenzo Rizzo
1Department of Neuroscience, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy. angelo.quartarone@unime.it
Muscle & Nerve
|January 16, 2007
Summary
Researchers investigated transcranial direct-current stimulation (tDCS) effects on motor cortex excitability in amyotrophic lateral sclerosis (ALS) patients. ALS patients showed no change, unlike healthy controls, suggesting a potential neurophysiological marker for upper motoneuron disease.
Area of Science:
- Neuroscience
- Neurology
- Electrophysiology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting upper and lower motor neurons.
- Identifying reliable neurophysiological markers for upper motor neuron (UMN) involvement is crucial for ALS diagnosis and management.
- Transcranial direct-current stimulation (tDCS) is a non-invasive brain stimulation technique that can modulate cortical excitability.
Purpose of the Study:
- To identify a neurophysiological marker for upper motor neuron involvement in sporadic amyotrophic lateral sclerosis (ALS).
- To evaluate the after-effects of transcranial direct-current stimulation (tDCS) on motor cortex excitability in ALS patients and healthy controls.
Main Methods:
- Eight patients with sporadic ALS and eight healthy controls underwent transcranial direct-current stimulation (tDCS).
- Motor cortex excitability was assessed by measuring corticospinal excitability changes following anodal and cathodal tDCS.
Main Results:
- Healthy controls exhibited significant, polarity-specific changes in corticospinal excitability (+/-45%) after tDCS (anodal: facilitation, cathodal: inhibition).
- ALS patients demonstrated no significant changes in corticospinal excitability following either anodal or cathodal tDCS.
Conclusions:
- The absence of tDCS after-effects in ALS patients suggests potential alterations in the motoneuronal membrane or disordered glutamate neurotransmission.
- These findings may indicate a novel and reliable electrophysiological marker for upper motor neuron involvement in ALS.
- Further research is warranted to validate these results and explore their clinical implications.


